Anca Chelariu-Raicu

12PUBLICATIONS
24CO-AUTHORS
AutoimmunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 03, 2025
IMGN853 Induces Autophagic Cell Death in Combination Therapy for Ovarian Cancer.

Anca Chelariu-Raicu, Thanh Chung Vu, Sujanitha Umamaheswaran

|Jul 10, 2024
Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine.

Jibran Ahmed, Carlos Torrado, Anca Chelariu

|Aug 28, 2023
Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation.

Anca Chelariu-Raicu, Sarina A Piha-Paul, Mariana Chavez-MacGregor

|Mar 06, 2023
Integrating antibody drug conjugates in the management of gynecologic cancers.

Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore

|Jan 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy.

Anca Chelariu-Raicu, Fabian Trillsch, Alexander Burges

|Feb 21, 2022
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.

Anca Chelariu-Raicu, Eva Holley, Doris Mayr

Pageof 2